Literature DB >> 10638898

Propofol for monitored anesthesia care: implications on hypoxic control of cardiorespiratory responses.

D Nieuwenhuijs1, E Sarton, L Teppema, A Dahan.   

Abstract

BACKGROUND: Hypoxia has a dual effect on ventilation: an initial period of hyperventilation, the acute hypoxic response, is followed after 3-5 min by a slow decline, the hypoxic ventilatory decline. Because of hypoxic ventilatory decline, subsequent acute hypoxic responses are depressed. In this study, the influence of a sedative concentration of propofol on ventilation was studied if hypoxia was sustained and intermittent.
METHODS: Ten healthy young male volunteers performed two hypoxic tests without and with a target controlled infusion of propofol. The sustained hypoxic test consisted of 15 min of isocapnic hypoxia followed by 2 min of normoxia and 3 min of hypoxia. The test of hypoxic pulses involved six subsequent exposures to 3 min hypoxia followed by 2 min of normoxia. The bispectral index of the electroencephalogram was measured to obtain an objective measure of sedation.
RESULTS: Blood propofol concentrations varied among subjects but were stable over time (mean blood concentration 0.6 microg/ml). The sustained hypoxic test showed that propofol decreased acute hypoxic response by approximately 50% and that the magnitude of hypoxic ventilatory decline relative to acute hypoxic response was increased by > 50%. Propofol increased the depression of the acute hypoxic response after 15 min of hypoxia by approximately 25%. In control and propofol studies, no hypoxic ventilatory decline was generated during exposure to hypoxic pulses. The bispectral index-acute hypoxic response data suggest that subjects were either awake (with minimal effect on acute hypoxic response) or sedated (with 50-60% reduction of acute hypoxic response).
CONCLUSIONS: The depression of acute hypoxic response results from an effect of propofol at peripheral or central sites involved in respiratory control or secondary to the induction of sedation or hypnosis by propofol. The relative increase in hypoxic ventilatory decline is possibly related to propofol's action at the gamma-aminobutyric acid A (GABA(A)) receptor complex, causing increased GABAergic inhibition of ventilation during sustained (but not intermittent) hypoxia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10638898     DOI: 10.1097/00000542-200001000-00013

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  13 in total

1.  Antioxidants prevent depression of the acute hypoxic ventilatory response by subanaesthetic halothane in men.

Authors:  Luc J Teppema; Diederik Nieuwenhuijs; Elise Sarton; Raymonda Romberg; Cees N Olievier; Denham S Ward; Albert Dahan
Journal:  J Physiol       Date:  2002-11-01       Impact factor: 5.182

2.  Fiberoptic bronchoscopy under noninvasive ventilation and propofol target-controlled infusion in hypoxemic patients.

Authors:  Benjamin Clouzeau; Hoang-Nam Bui; Emmanuelle Guilhon; Marieke Grenouillet-Delacre; Melanie Saint Leger; Tahar Saghi; Jerome Pillot; Bruno Filloux; Solenn Coz; Alexandre Boyer; Frederic Vargas; Didier Gruson; Gilles Hilbert
Journal:  Intensive Care Med       Date:  2011-10-08       Impact factor: 17.440

Review 3.  The Role of GABA Receptor Agonists in Anesthesia and Sedation.

Authors:  Janette Brohan; Basavana G Goudra
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

Review 4.  Strategies to optimise propofol-opioid anaesthesia.

Authors:  Bart-Jan Lichtenbelt; Martijn Mertens; Jaap Vuyk
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

5.  Propofol enhances both tonic and phasic inhibitory currents in second-order neurons of the solitary tract nucleus (NTS).

Authors:  Stuart J McDougall; Timothy W Bailey; David Mendelowitz; Michael C Andresen
Journal:  Neuropharmacology       Date:  2007-11-07       Impact factor: 5.250

6.  Target-controlled infusion of propofol for sedation in patients with non-invasive ventilation failure due to low tolerance: a preliminary study.

Authors:  Benjamin Clouzeau; Hoang-Nam Bui; Frederic Vargas; Marieke Grenouillet-Delacre; Emmanuelle Guilhon; Didier Gruson; Gilles Hilbert
Journal:  Intensive Care Med       Date:  2010-05-11       Impact factor: 17.440

7.  A comparison of equisedative infusions of propofol and midazolam for conscious sedation during spinal anesthesia - a prospective randomized study.

Authors:  Abhiruchi Patki; V C Shelgaonkar
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-01

8.  The effect-site concentration of propofol producing respiratory depression during spinal anesthesia.

Authors:  Mi Hyeon Lee; Ki-Hwan Yang; Choon Soo Lee; Hong Sik Lee; Sin Yeong Moon; Sung-Il Hwang; Jang-Ho Song
Journal:  Korean J Anesthesiol       Date:  2011-08-23

9.  Sedation in hypoalbuminemic geriatric patients under spinal anesthesia in hip surgery. Midazolam or Propofol?

Authors:  Ayşın Ersoy; Deniz Kara; Zekeriya Ervatan; Mensure Çakırgöz; Özlem Kıran
Journal:  Saudi Med J       Date:  2015-10       Impact factor: 1.484

Review 10.  Clinical Pharmacokinetics and Pharmacodynamics of Propofol.

Authors:  Marko M Sahinovic; Michel M R F Struys; Anthony R Absalom
Journal:  Clin Pharmacokinet       Date:  2018-12       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.